EPR Healthcare News

November 5th 2009
Categories: Alternative medicine, Clinics, Consultations, Cosmetic Surgery, Healthcare, Healthcare Professionals, Healthcare Services, Liposuction, Obesity, Surgeons, Surgery, Weight loss

No Comments

Obesity and Society

Obese and overweight people are forecast to cost the nation £50 billion – half the NHS budget for a year – by 2050 if the trend continues unchecked, with diabetes the biggest draw on these figures.* The NHS spends an estimated £600m a year on treating diabetes – the largest in ...
November 5th 2009
Categories: Biotech, Business of Medicine, Healthcare, Healthcare Information, Medicine, Pharmaceuticals

No Comments

Catalent Expands Capabilities In Testing For Melamine In Food And Medicinal Products

At a time when melamine-contamination has received global attention, Catalent Pharma Solutions continues its legacy of innovation by rapidly developing new FDA guidance-compliant tests for trace amounts of key contaminants in food and medicine. Incidents of melamine contamination in milk products, baby formula, dairy and non-dairy products manufactured in China ...

Pages

 

November 2009
M T W T F S S
« Oct   Dec »
 1
2345678
9101112131415
16171819202122
23242526272829
30  

Advertisements

Categories

Recent Posts

Tags

Blogroll

Archives

Meta

September 3rd 2010
Tags: Biotech, Business of Medicine, Diseases, Drugs, Healthcare, Healthcare Information, Healthcare Professionals, Healthcare Solutions, Medicine, Online, Pharmaceuticals, Society No Comments

Medicines for Malaria Venture (MMV) Joins The Pool for Open Innovation Against Neglected Tropical Diseases

Global Health Progress (GHP) is pleased to highlight the announcement that the not-for-profit public-private partnership Medicines for Malaria Venture (MMV) will became the first product development partnership (PDP) to contribute intellectual property to The Pool for Open Innovation against Neglected Tropical Diseases (The Pool). MMV joined GlaxoSmithKline (GSK), Alnylam Pharmaceuticals, and ...
September 3rd 2010
Tags: Alternative medicine, Business of Medicine, Drugs, Health Products, Healthcare, Healthcare Products, Medicine, Pharmaceuticals No Comments

Zetathermide Proven to Generate Hi Levels of Far Infrared at Very Low Temperatures

The ZTG Group has completed it’s six year development cycle and independent 3rd party testing of a new material titled ZetathermideTM. Zetathermide has been proven effective in emitting high levels of Far-Infrared at very low temperatures. The completion of Zetathermide’s development is extremely relevant to the fields of chiropractic care, physical ...

Search

The archives run deep. Feel free to search older content using topic keywords.